Clinical Research Directory

Inclusion Criteria: * Age ≥18 years * Ischemic or hemorrhagic stroke confirmed by MRI or scanner * Lesion(s) in somato-sensory areas (i.e. mainly in: the pons, thalamus, internal capsule, basal ganglia and operculo-insular regions) * Sensory and/or motor deficit requiring rehabilitation * Subacute stage (7 to 45 days post-stroke) * No neurological deficit or chronic neuropathic pain prior to stroke * No neuropathic pain at inclusion * Patient can be followed throughout the study. * Information letter read and understood * Able to give informed consent to participate in research * Affiliation with a social security scheme Exclusion Criteria: * Contraindication to tDCS (epilepsy/history of epilepsy, intracranial ferromagnetic material or implanted stimulator, acute eczema or irritated skin over the stimulation area) * Contraindication to MRI (use of a pacemaker or insulin pump, wearing of a metal prosthesis, intracerebral clip or piercing, claustrophobia) * Cognitive or language difficulties preventing comprehension of instructions and/or correct clinical assessment * Patients participating in another research protocol involving a drug in the 30 days prior to inclusion * Drug or psychoactive substance abuse * Pregnant or breast-feeding women * Patients under guardianship or curatorship, deprived of liberty, safeguard of justice * Major depression * Patients with Parkinson's disease * The presence of pre-existing lesions \>1.5 cm (maximum diameter) in a cerebral area belonging to the anatomically defined sensorimotor system * Alcohol abuse * Severe psychiatric disorders (e.g., schizophrenia) * Any tumor disease with a life expectancy of \<1 year * Increased intracranial pressure * Patients with a medical device containing electronics or conductive materials * Patients on continuous oxygen (system not adapted)